News | July 11, 2022
India’s first homegrown mRNA COVID-19 vaccine likely to have low market penetration, says GlobalData
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.
Glenmark is the first company in India to market the innovative FDC of Indacaterol
Viralex (Inosine Pranobex) is an immunomodulatory agent with broad-spectrum antiviral properties
The procedures have been performed by Dr. Kaushal Pandey at P.D. Hinduja Hospital in Mumbai, India
The approval by the DCGI comes following recommendations by the Subject Expert Committee (SEC) on Covid-19 of the Central Drugs Standard Control Organisation(CDSCO)
Trelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is associated with less inhaler teaching time compared to other commonly used inhalers
The innovative Fixed-Dose Combination will help improving the glycemic control among adult patients with insulin resistance, those whose diabetes is uncontrolled by metformin; and also those who require addition of Teneliglitptin and Pioglitazone as separate drugs.
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
Subscribe To Our Newsletter & Stay Updated
